Complexes of HIV-1 reverse transcriptase with Inhibitors of the HEPT Series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors - Hopkins, A L; Ren, J; Esnouf, R M (J Med Chem, 1996)
et al.